Table 2.
Correlations of HIF-1α mRNA and protein with clinicopathological characters
| HIF-1α mRNA | HIF-1α protein | |||||
|---|---|---|---|---|---|---|
| low | high | P | low | high | P | |
| Patients | 68 | 42 | 71 | 39 | ||
| Age(years) | ||||||
| ≤52 | 28 | 26 | 0.049 | 32 | 22 | 0.320 |
| >52 | 40 | 16 | 39 | 17 | ||
| Sex | ||||||
| Male | 57 | 38 | 0.40 | 57 | 38 | 0.017 |
| Female | 11 | 4 | 14 | 1 | ||
| Hepatitis history | ||||||
| Yes | 61 | 39 | 0.739 | 62 | 38 | 0.094 |
| No | 7 | 3 | 9 | 1 | ||
| Preoperative AFP(ng/ml) | ||||||
| ≤20 | 29 | 16 | 0.693 | 33 | 12 | 0.156 |
| >20 | 39 | 26 | 38 | 27 | ||
| Liver cirrhosis | ||||||
| Yes | 59 | 34 | 0.428 | 56 | 37 | 0.029 |
| No | 9 | 8 | 15 | 2 | ||
| ALT(U/L) | ||||||
| ≤40 | 36 | 22 | 1.000 | 38 | 20 | 0.844 |
| >40 | 32 | 20 | 33 | 19 | ||
| Γ-GT(U/L) | ||||||
| ≤54 | 30 | 14 | 0.318 | 31 | 13 | 0.316 |
| >54 | 38 | 28 | 40 | 26 | ||
| Tumor size (cm) | ||||||
| ≤5 | 35 | 21 | 1.000 | 33 | 23 | 0.236 |
| >5 | 33 | 21 | 38 | 16 | ||
| Tumor encapsulation | ||||||
| Yes | 31 | 18 | 0.845 | 32 | 17 | 1.000 |
| No | 37 | 24 | 39 | 22 | ||
| Tumor number | ||||||
| Single | 53 | 32 | 0.820 | 56 | 29 | 0.638 |
| Multiple | 15 | 10 | 15 | 10 | ||
| Vascular invasion | ||||||
| Yes | 26 | 25 | 0.033 | 27 | 24 | 0.027 |
| No | 42 | 17 | 44 | 15 | ||
| BCLC stage | ||||||
| A | 30 | 10 | 0.041 | 31 | 9 | 0.039 |
| B + C | 38 | 32 | 40 | 30 | ||
| Tumor differentiation | ||||||
| I+II | 40 | 18 | 0.119 | 36 | 22 | 0.690 |
| III+IV | 28 | 24 | 35 | 17 | ||
| Prophylactic treatment | ||||||
| Yes | 33 | 22 | 0.845 | 31 | 24 | 0.110 |
| No | 35 | 20 | 39 | 16 | ||
Detailed legends: Fisher's exact tests were used for all the analysis of correlations.